NCT00606242View on ClinicalTrials.gov

Dose Response Effects of Inhaled Fluticasone on Airway Effects of Hypertonic-saline in Asthma

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2007

Conditions
Asthma
Interventions
DRUG

Fluticasone

Inhaled Fluticasone, either 100 or 1000 mcg per day

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

GlaxoSmithKline

INDUSTRY

lead

University of California, San Francisco

OTHER

NCT00606242 - Dose Response Effects of Inhaled Fluticasone on Airway Effects of Hypertonic-saline in Asthma | Biotech Hunter | Biotech Hunter